Metraipolis › archive › dc_82ef111b4620

Histologic Transformation in Follicular Lymphoma: Real-World Outcomes with Rituximab vs. Obinutuzumab-Based Combinations — Europe PMC PMID:42122267

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42122267
DOI
10.3390/cancers18091471
License (as archived)
solo-consultazione
Archived
2026-11-02T20:11:05.160Z
SHA-256 of the archived text
debe9b920ba87b43a2aa4120bf80946f1f6cc95e5a37642db57bc01aebf43c11
Stable URL of this page
https://metraipolis.com/documento/dc_82ef111b4620

How to cite

Histologic Transformation in Follicular Lymphoma: Real-World Outcomes with Rituximab vs. Obinutuzumab-Based Combinations — Europe PMC PMID:42122267 — Europe PMC (en), https://europepmc.org/article/MED/42122267 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_82ef111b4620 (Metraipolis archive dc_82ef111b4620, sha256 debe9b920ba87b43a2aa4120bf80946f1f6cc95e5a37642db57bc01aebf43c11)
BibTeX
@misc{dc82ef111b4620,
  title = {Histologic Transformation in Follicular Lymphoma: Real-World Outcomes with Rituximab vs. Obinutuzumab-Based Combinations — Europe PMC PMID:42122267},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42122267},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_82ef111b4620; sha256 debe9b920ba87b43a2aa4120bf80946f1f6cc95e5a37642db57bc01aebf43c11},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42122267. Agents can read the archived copy with the MCP tool read_document.